Evaluation of Clinical Course and Maintenance Drug Treatment of Supraventricular Tachycardia in Children During the First Years of Life. A Cohort Study from Eastern Germany.
Children
Drug therapy
ECG
Supraventricular tachycardia
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
15
05
2021
accepted:
01
09
2021
pubmed:
16
9
2021
medline:
19
2
2022
entrez:
15
9
2021
Statut:
ppublish
Résumé
Supraventricular tachycardia (SVT) is considered the most common cause of arrhythmia in children and infants. Regarding the likelihood of a spontaneous resolution of SVTs during the first years of life, drug treatment aims to bridge the time until children 'grow out' out of the arrhythmia. The choice of antiarrhythmic agents and the planning of maintenance therapy are mainly based on clinical experience and retrospective single- and multi-institutional analyses and databases from all over the world approaching differently to this topic. The current study aimed to evaluate the clinical course, pharmacological treatment strategies, and constellations of risk for recurrences in the management of SVTs in children aged 3 < years. The database of the Heart Center Leipzig, Department of Pediatric cardiology, was searched for pediatric patients aged < 3 years with a clinically documented SVT between 2000 and 2019 that received pharmacologic treatment. Patients with complex congenital heart disease or arrhythmias following cardiac surgery were excluded. 69 patients were included. Pharmacologic treatment, follow-up schedule, recurrences, outcomes, and risk factors for complicated courses are reported. Drug therapy of SVTs in young children remains a controversial topic with heterogeneous treatment and follow-up strategies applied. Risk factors for recurrences and/or stubborn clinical courses are difficult rhythm control with 3 or more antiarrhythmic drugs, ectopic atrial tachycardias, and a first occurrence of the SVT in the fetal period. Prospective studies are needed to sufficiently evaluate optimal treatment strategies.
Identifiants
pubmed: 34524484
doi: 10.1007/s00246-021-02724-9
pii: 10.1007/s00246-021-02724-9
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
332-343Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Weindling SN, Saul JP, Walsh EP (1996) Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 131:66–72. https://doi.org/10.1016/S0002-8703(96)90052-6
doi: 10.1016/S0002-8703(96)90052-6
pubmed: 8554021
Garson A, Gillette PC, McNamara DG (1981) Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 98:875–882. https://doi.org/10.1016/s0022-3476(81)80578-1
doi: 10.1016/s0022-3476(81)80578-1
pubmed: 7229788
Brugada J, Blom N, Sarquella-Brugada G et al (2013) Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace 15:1337–1382. https://doi.org/10.1093/europace/eut082
doi: 10.1093/europace/eut082
pubmed: 23851511
Kugler JD, Danford DA, Houston K et al (1997) Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry. Am J Cardiol 80:1438–1443. https://doi.org/10.1016/s0002-9149(97)00736-4
doi: 10.1016/s0002-9149(97)00736-4
pubmed: 9399718
Bjeloševič M, Illíková V, Tomko J et al (2020) Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: a 10-year population-based study. Pacing Clin Electrophysiol 43:680–686. https://doi.org/10.1111/pace.13964
doi: 10.1111/pace.13964
pubmed: 32459027
Seslar SP, Garrison MM, Larison C et al (2013) A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborns and infants. Pediatr Cardiol 34:408–414. https://doi.org/10.1007/s00246-012-0474-6
doi: 10.1007/s00246-012-0474-6
pubmed: 22903738
Wong KK, Potts JE, Etheridge SP et al (2006) Medications used to manage supraventricular tachycardia in the infant a North American survey. Pediatr Cardiol 27:199–203. https://doi.org/10.1007/s00246-005-1126-x
doi: 10.1007/s00246-005-1126-x
pubmed: 16391988
Ko JK, Deal BJ, Strasburger JF et al (1992) Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 69:1028–1032. https://doi.org/10.1016/0002-9149(92)90858-v
doi: 10.1016/0002-9149(92)90858-v
pubmed: 1561973
Pfammatter JP, Bauersfeld U (1998) Safety issues in the treatment of paediatric supraventricular tachycardias. Drug Saf 18:345–356. https://doi.org/10.2165/00002018-199818050-00004
doi: 10.2165/00002018-199818050-00004
pubmed: 9589846
Paul T, Bertram H, Bökenkamp R et al (2000) Supraventricular tachycardia in infants, children and adolescents: diagnosis, and pharmacological and interventional therapy. Paediatr Drugs 2:171–181. https://doi.org/10.2165/00128072-200002030-00002
doi: 10.2165/00128072-200002030-00002
pubmed: 10937468
Ge H, Li X, Liu H et al (2017) Predictors of pharmacological therapy of ectopic atrial tachycardia in children. Pediatr Cardiol 38:289–295. https://doi.org/10.1007/s00246-016-1511-7
doi: 10.1007/s00246-016-1511-7
pubmed: 27882422
Masarone D, Valente F, Rubino M et al (2017) Pediatric heart failure: a practical guide to diagnosis and management. Pediatr Neonatol 58:303–312. https://doi.org/10.1016/j.pedneo.2017.01.001
doi: 10.1016/j.pedneo.2017.01.001
pubmed: 28279666
Perry JC, Garson A (1990) Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 16:1215–1220. https://doi.org/10.1016/0735-1097(90)90555-4
doi: 10.1016/0735-1097(90)90555-4
pubmed: 2229769
Nadas AS, Daeschner CW, Roth A et al (1952) Paroxysmal tachycardia in infants and children; study of 41 cases. Pediatrics 9:167–181
pubmed: 14911279
Andersen ED, Jacobsen JR, Sandoe E et al (1973) Paroxysmal tachycardia in infancy and childhood. I. Paroxysmal supraventricular tachycardia. Acta Paediatr Scand 62:341–348. https://doi.org/10.1111/j.1651-2227.1973.tb08118.x
doi: 10.1111/j.1651-2227.1973.tb08118.x
pubmed: 4729685
Tortoriello TA, Snyder CS, Smith EO’B et al (2003) Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy. Am J Cardiol 92:1045–1049. https://doi.org/10.1016/j.amjcard.2003.06.002
doi: 10.1016/j.amjcard.2003.06.002
pubmed: 14583354
Sanatani S, Potts JE, Reed JH et al (2012) The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 5:984–991. https://doi.org/10.1161/CIRCEP.112.972620
doi: 10.1161/CIRCEP.112.972620
pubmed: 22962431
Gilljam T, Jaeggi E, Gow RM (2008) Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatrica (Oslo, Norway:1992) 97:1035–1039. https://doi.org/10.1111/j.1651-2227.2008.00823.x
doi: 10.1111/j.1651-2227.2008.00823.x
Wu MH, Chang YC, Lin JL et al (1994) Probability of supraventricular tachycardia recurrence in pediatric patients. Cardiology 85:284–289. https://doi.org/10.1159/000176697
doi: 10.1159/000176697
pubmed: 7850817
Riggs TW, Byrd JA, Weinhouse E (1999) Recurrence risk of supraventricular tachycardia in pediatric patients. Cardiology 91:25–30. https://doi.org/10.1159/000006873
doi: 10.1159/000006873
pubmed: 10393395
van Engelen AD, Weijtens O, Brenner JI et al (1994) Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 24:1371–1375. https://doi.org/10.1016/0735-1097(94)90122-8
doi: 10.1016/0735-1097(94)90122-8
pubmed: 7930263
Hahurij ND, Blom NA, Lopriore E et al (2011) Perinatal management and long-term cardiac outcome in fetal arrhythmia. Early Hum Dev 87:83–87. https://doi.org/10.1016/j.earlhumdev.2010.11.001
doi: 10.1016/j.earlhumdev.2010.11.001
pubmed: 21109370
Simpson JM, Milburn A, Yates RW et al (1997) Outcome of intermittent tachyarrhythmias in the fetus. Pediatr Cardiol 18:78–82. https://doi.org/10.1007/s002469900118
doi: 10.1007/s002469900118
pubmed: 9049114
O’Leary ET, Alexander ME, Bezzerides VJ et al (2020) Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol 31:1105–1113. https://doi.org/10.1111/jce.14406
doi: 10.1111/jce.14406
pubmed: 32100356
Guerrier K, Shamszad P, Czosek RJ et al (2016) Variation in antiarrhythmic management of infants hospitalized with supraventricular tachycardia: a multi-institutional analysis. Pediatr Cardiol 37:946–952. https://doi.org/10.1007/s00246-016-1375-x
doi: 10.1007/s00246-016-1375-x
pubmed: 27033244
Kang KT, Etheridge SP, Kantoch MJ et al (2014) Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol 7:664–670. https://doi.org/10.1161/CIRCEP.113.001423
doi: 10.1161/CIRCEP.113.001423
pubmed: 25015944
Janousek J, Paul T (1998) Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists. Am J Cardiol 81:1121–1124. https://doi.org/10.1016/s0002-9149(98)00142-8
doi: 10.1016/s0002-9149(98)00142-8
pubmed: 9605053
Pfammatter JP, Paul T, Lehmann C et al (1995) Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 26:1002–1007. https://doi.org/10.1016/0735-1097(95)00268-3
doi: 10.1016/0735-1097(95)00268-3
pubmed: 7560592
Tipple M, Sandor G (1991) Efficacy and safety of oral sotalol in early infancy. Pacing Clin Electrophysiol 14:2062–2065. https://doi.org/10.1111/j.1540-8159.1991.tb02816.x
doi: 10.1111/j.1540-8159.1991.tb02816.x
pubmed: 1721225
Pfammatter JP, Paul T (1997) New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol 18:28–34. https://doi.org/10.1007/s002469900104
doi: 10.1007/s002469900104
pubmed: 8960489